Works matching IS 0008543X AND DT 2012 AND VI 118 AND IP 1


Results: 48
    2

    Exemestane versus anastrozole as front-line endocrine therapy in postmenopausal patients with hormone receptor-positive, advanced breast cancer: final results from the Spanish Breast Cancer Group 2001-03 phase 2 randomized trial.

    Published in:
    2012
    By:
    • Llombart-Cussac A;
    • Ruiz A;
    • Antón A;
    • Barnadas A;
    • Antolín S;
    • Alés-Martínez JE;
    • Alvarez I;
    • Andrés R;
    • García Saenz JA;
    • Lao J;
    • Carrasco E;
    • Cámara C;
    • Casas I;
    • Martín M;
    • Llombart-Cussac, Antonio;
    • Ruiz, Amparo;
    • Antón, Antonio;
    • Barnadas, Agustí;
    • Antolín, Silvia;
    • Alés-Martínez, José E
    Publication type:
    journal article
    3
    4
    5
    6
    7

    Expanding Nilotinib Access in Clinical Trials (ENACT): an open-label, multicenter study of oral nilotinib in adult patients with imatinib-resistant or imatinib-intolerant Philadelphia chromosome-positive chronic myeloid leukemia in the chronic phase.

    Published in:
    2012
    By:
    • Nicolini FE;
    • Turkina A;
    • Shen ZX;
    • Gallagher N;
    • Jootar S;
    • Powell BL;
    • De Souza C;
    • Zheng M;
    • Szczudlo T;
    • le Coutre P;
    • Nicolini, Franck E;
    • Turkina, Anna;
    • Shen, Zhi-Xiang;
    • Gallagher, Neil;
    • Jootar, Saengsuree;
    • Powell, Bayard L;
    • De Souza, Carmino;
    • Zheng, Ming;
    • Szczudlo, Tomasz;
    • le Coutre, Philipp
    Publication type:
    journal article
    8
    9
    10
    11
    12
    14
    15
    16
    17

    Conflict of interest in oncology publications.

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 1, p. 188, doi. 10.1002/cncr.26237
    By:
    • Kesselheim, Aaron S.;
    • Lee, Joy L.;
    • Avorn, Jerry;
    • Servi, Amber;
    • Shrank, William H.;
    • Choudhry, Niteesh K.
    Publication type:
    Article
    18
    19
    20

    Dasatinib combined with docetaxel for castration-resistant prostate cancer.

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 1, p. 63, doi. 10.1002/cncr.26204
    By:
    • Araujo, John C.;
    • Mathew, Paul;
    • Armstrong, Andrew J.;
    • Braud, Edward L.;
    • Posadas, Edwin;
    • Lonberg, Mathew;
    • Gallick, Gary E.;
    • Trudel, Géralyn C.;
    • Paliwal, Prashni;
    • Agrawal, Shruti;
    • Logothetis, Christopher J.
    Publication type:
    Article
    21
    22
    23
    24
    25

    Post-therapy pathologic stage and survival in patients with pancreatic ductal adenocarcinoma treated with neoadjuvant chemoradiation.

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 1, p. 268, doi. 10.1002/cncr.26243
    By:
    • Estrella, Jeannelyn S.;
    • Rashid, Asif;
    • Fleming, Jason B.;
    • Katz, Matthew H.;
    • Lee, Jeffrey E.;
    • Wolf, Robert A.;
    • Varadhachary, Gauri R.;
    • Pisters, Peter W. T.;
    • Abdalla, Eddie K.;
    • Vauthey, Jean-Nicolas;
    • Wang, Hua;
    • Gomez, Henry F.;
    • Evans, Douglas B.;
    • Abbruzzese, James L.;
    • Wang, Huamin
    Publication type:
    Article
    26
    27
    28
    29

    Serum cell-free DNA in renal cell carcinoma.

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 1, p. 82, doi. 10.1002/cncr.26254
    By:
    • de Martino, Michela;
    • Klatte, Tobias;
    • Haitel, Andrea;
    • Marberger, Michael
    Publication type:
    Article
    30
    31
    32
    33
    34
    35
    36
    37
    38
    39
    40
    41
    42
    43
    44
    45
    46
    47
    48

    Expanding Nilotinib Access in Clinical Trials (ENACT).

    Published in:
    Cancer (0008543X), 2012, v. 118, n. 1, p. 118, doi. 10.1002/cncr.26249
    By:
    • Nicolini, Franck E.;
    • Turkina, Anna;
    • Shen, Zhi-Xiang;
    • Gallagher, Neil;
    • Jootar, Saengsuree;
    • Powell, Bayard L.;
    • De Souza, Carmino;
    • Zheng, Ming;
    • Szczudlo, Tomasz;
    • le Coutre, Philipp
    Publication type:
    Article